6-16238710-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006877.4(GMPR):c.17C>T(p.Ala6Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000769 in 1,430,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006877.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GMPR | NM_006877.4 | c.17C>T | p.Ala6Val | missense_variant | 1/9 | ENST00000259727.5 | NP_006868.3 | |
GMPR | XM_047418656.1 | c.17C>T | p.Ala6Val | missense_variant | 1/9 | XP_047274612.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GMPR | ENST00000259727.5 | c.17C>T | p.Ala6Val | missense_variant | 1/9 | 1 | NM_006877.4 | ENSP00000259727.4 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151590Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000194 AC: 2AN: 103294Hom.: 0 AF XY: 0.0000177 AC XY: 1AN XY: 56550
GnomAD4 exome AF: 0.00000782 AC: 10AN: 1279032Hom.: 0 Cov.: 28 AF XY: 0.00000476 AC XY: 3AN XY: 629616
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151700Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74132
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.17C>T (p.A6V) alteration is located in exon 1 (coding exon 1) of the GMPR gene. This alteration results from a C to T substitution at nucleotide position 17, causing the alanine (A) at amino acid position 6 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at